Christine Wilkinson Blanc is an innovative inventor based in Abingdon, Great Britain. With a significant contribution to the field of medical treatments, she holds two patents focused on therapeutic methodologies involving adenoviruses. Her work exemplifies the intersection of advanced science and practical application.

Latest Patents

Among her latest inventions are two notable patents concerning dosing regimes and formulations for type B adenoviruses. The first patent outlines a comprehensive method for treating human patients by systematically administering multiple doses of a parenteral formulation of a replication-capable oncolytic adenovirus of subgroup B within a single treatment cycle. This method details a dosing range of 1×10 to 1×10 viral particles, where each dose is delivered over 1 to 90 minutes. Furthermore, this innovation explores the administration rate of viral particles, proposing a delivery speed of 2×10 particles per minute to 2×10 particles per minute. Additionally, these patents encompass formulations of oncolytic adenoviruses and their combination therapies with other therapeutic agents, broadening the scope of potential treatment options.

Career Highlights

Christine has built an impressive career within the biotechnology sector, contributing her expertise to reputable companies such as Psioxus Therapeutics Limited and Akamis Bio Limited. Her experience in these organizations has further honed her skills and contributed to her success as an inventor.

Collaborations

Throughout her career, Christine Wilkinson Blanc has collaborated with notable professionals, including Kerry David Fisher and John William Beadle. These partnerships have played a significant role in advancing her work and bringing innovative solutions to market.

Conclusion

Christine Wilkinson Blanc's dedication to medical innovation and her impressive patent portfolio reflect her significant impact on the field. Her ongoing contributions to the development of treatments using adenoviruses not only showcase her inventiveness but also enhance the quality of care available to patients. With a promising career ahead, she stands out as a notable inventor in the realm of biotechnology.

This text is generated by artificial intelligence and may not be accurate.